James M. Mock - 26 Nov 2025 Form 4 Insider Report for Moderna, Inc. (MRNA)

Role
Chief Financial Officer
Signature
/s/ James Dillon, As Attorney-in-Fact
Issuer symbol
MRNA
Transactions as of
26 Nov 2025
Transactions value $
$-13,258
Form type
4
Filing time
01 Dec 2025, 16:27:41 UTC
Previous filing
06 Oct 2025
Next filing
08 Dec 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Mock James M Chief Financial Officer C/O MODERNA, INC., 325 BINNEY STREET, CAMBRIDGE /s/ James Dillon, As Attorney-in-Fact 01 Dec 2025 0001736359

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction MRNA Common Stock Options Exercise +773 +4.23% 19,032 26 Nov 2025 Direct F1
transaction MRNA Common Stock Tax liability $-9,256 -374 -1.97% $24.75 18,658 26 Nov 2025 Direct F2
transaction MRNA Common Stock Options Exercise +329 +1.76% 18,987 28 Nov 2025 Direct F1
transaction MRNA Common Stock Tax liability $-4,002 -160 -0.84% $25.01 18,827 28 Nov 2025 Direct F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction MRNA Restricted Stock Units Options Exercise $0 -773 -9.99% $0.000000 6,963 26 Nov 2025 Common Stock 773 Direct F1, F3
transaction MRNA Restricted Stock Units Options Exercise $0 -329 -16.7% $0.000000 1,644 28 Nov 2025 Common Stock 329 Direct F1, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Restricted stock units convert into common stock on a one-for-one basis.
F2 Represents shares withheld at the election of the Reporting Person to satisfy tax withholding obligations in connection with the vest of restricted stock units.
F3 25% of the shares subject to this restricted stock unit award vested on February 27, 2025 with the remainder vesting in twelve (12) equal quarterly installments thereafter.
F4 25% of the shares subject to this restricted stock unit award vested on February 28, 2024 with the remainder vesting in twelve (12) equal quarterly installments thereafter.